These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34321843)

  • 1. Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic.
    Inchingolo R; Acquafredda F; Tedeschi M; Laera L; Surico G; Surgo A; Fiorentino A; Spiliopoulos S; de'Angelis N; Memeo R
    World J Gastroenterol; 2021 Jul; 27(25):3780-3789. PubMed ID: 34321843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement.
    Chagas AL; Fonseca LGD; Coelho FF; Saud LRDC; Abdala E; Andraus W; Fiore L; Moreira AM; Menezes MR; Carnevale FC; Tani CM; Alencar RSSM; D'Albuquerque LAC; Herman P; Carrilho FJ
    Clinics (Sao Paulo); 2020; 75():e2192. PubMed ID: 33146360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.
    Barry A; Apisarnthanarax S; O'Kane GM; Sapisochin G; Beecroft R; Salem R; Yoon SM; Lim YS; Bridgewater J; Davidson B; Scorsetti M; Solbiati L; Diehl A; Schuffenegger PM; Sham JG; Cavallucci D; Galvin Z; Dawson LA; Hawkins MA
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):765-775. PubMed ID: 32511951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional oncology at the time of COVID-19 pandemic: Problems and solutions.
    Denys A; Guiu B; Chevallier P; Digklia A; de Kerviler E; de Baere T
    Diagn Interv Imaging; 2020 Jun; 101(6):347-353. PubMed ID: 32360351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
    Mehta N; Parikh ND; Kelley RK; Hameed B; Singal AG
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1520-1530. PubMed ID: 32652308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Hepatocellular Cancer in the time of SARS-CoV-2.
    Sharma R; Pinato DJ
    Liver Int; 2020 Aug; 40(8):1823-1825. PubMed ID: 32416633
    [No Abstract]   [Full Text] [Related]  

  • 7. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey.
    Zhao H; Zhou A; Zhou J; Bi X; Yan S; Jin J; Wei W; Li M; Gong C; Chen Q; Luo Z; Li N; Mao R; Chen X; Chen B; Zheng R; Zhao J; Han Y; Li Z; Che X; Tang Y; Sun Y; Huang Z; Zhang Y; Wang X; Zhang Y; Lu Z; Dang X; Song T; Liu C; Yue P; Yan D; Yue A; Zhang R; Luo S; Tan J; Zhang X; Bai X; Zhang X; He M; Xie Y; Wang W; Yang P; Yang Y; Zhang Y; Li Q; Peng T; Wang Z; Chen Y; Shang C; Liang Y; Zhang B; Zhang F; Wang L; Li D; Liu B; Zhu X; Hu Q; Chen M; Xiu D; Xia F; Zhang Y; Zeng Y; Mao Y; Li X; Ba Y; Liang T; Shen F; Liu L; Cai X; Zhou J; Cai J
    HPB (Oxford); 2022 Mar; 24(3):342-352. PubMed ID: 34400051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of liver diseases during the pandemic of coronavirus disease-19.
    Cho JY; Kim SS; Lee YS; Song DS; Lee JH; Kim JH
    Clin Mol Hepatol; 2020 Jul; 26(3):243-250. PubMed ID: 32570302
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline.
    Cho JY; Lee YS; Kim SS; Song DS; Lee JH; Kim JH
    Clin Mol Hepatol; 2021 Oct; 27(4):515-523. PubMed ID: 34530524
    [No Abstract]   [Full Text] [Related]  

  • 10. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
    Santambrogio R; Farina G; D'Alessandro V; Iacob G; Gemma M; Zappa MA
    J Laparoendosc Adv Surg Tech A; 2021 Mar; 31(3):266-272. PubMed ID: 32810426
    [No Abstract]   [Full Text] [Related]  

  • 12. Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic.
    Santambrogio R; Galfrascoli E; Zappa MA
    Dig Liver Dis; 2020 Sep; 52(9):950-952. PubMed ID: 32561303
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.
    Aghemo A; Masarone M; Montagnese S; Petta S; Ponziani FR; Russo FP;
    Dig Liver Dis; 2020 Sep; 52(9):937-941. PubMed ID: 32703730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor.
    Gambato M; Burra P
    Updates Surg; 2020 Jun; 72(2):237-239. PubMed ID: 32504266
    [No Abstract]   [Full Text] [Related]  

  • 15. [Impact of COVID-19 pandemic in liver transplantation in Argentina. Other collateral damage].
    Gondolesi GE; Reyes-Toso ML; Bisigniano L; de Santibañes M; Pekolj J; Maurette R; Quiñonez EG; Maraschio MA; Imventarza O; Lendoire J; Bitetti L; Ruf A; Aballay G; Gil O; Mattera FJ; Barros Schelotto P; Descalzi VI
    Medicina (B Aires); 2020; 80 Suppl 6():71-82. PubMed ID: 33481736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and gynecological cancer: a review of the published guidelines.
    Uwins C; Bhandoria GP; Shylasree TS; Butler-Manuel S; Ellis P; Chatterjee J; Tailor A; Stewart A; Michael A
    Int J Gynecol Cancer; 2020 Sep; 30(9):1424-1433. PubMed ID: 32576608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in the era of COVID-19: Is the worst yet to come?
    Mikolasevic I; Bozic D; Pavić T; Ruzic A; Hauser G; Radic M; Radic-Kristo D; Razov-Radas M; Puljiz Z; Milic S
    World J Gastroenterol; 2021 Sep; 27(36):6039-6052. PubMed ID: 34629818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.
    Chang JPE; Wong YJ; Yang WL; Lim KBL; Tan PS; Ho GH; Yip BCH; Li JW; Chong CH; Ong DEH; Chua TS; Vu CKF; Gwee KA; Ang TL; Tan CK
    Singapore Med J; 2020 Dec; 61(12):619-623. PubMed ID: 32349198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatocellular carcinoma in the time of COVID-19.
    Iavarone M; Sangiovanni A; Carrafiello G; Rossi G; Lampertico P
    Ann Oncol; 2020 Aug; 31(8):1084-1085. PubMed ID: 32330540
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Shah S; Diwan S; Soin A; Rajput K; Mahajan A; Manchikanti L; Kaye AD; Hirsch JA; Gharibo C
    Pain Physician; 2020 Aug; 23(4S):S161-S182. PubMed ID: 32942784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.